Get started
Work

Figure S1 from De Novo and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

Year: 2023
Type: other
Abstract: Figure S1. Lurbinectedin decreases cell viability in a time and dose-dependent manner.
DOI: 10.1158/1078-0432.23745758.v1
Authors: Subhamoy Chakraborty, Charles Coleman, Parvathy Manoj, Deniz Demircioglu, Nisargbhai Shah, Elisa de Stanchina, Charles M. Rudin, Dan Hasson, Triparna Sen
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4385250201
Cites:
Cited by:
Related to: 10